Outbreak of joint and soft-tissue infections associated with injections from a multiple-dose medication vial.

An outbreak of Staphylococcus aureus joint and soft-tissue infections occurred after therapeutic injections in an outpatient setting. A physician performed intra-articular or soft-tissue injections on 17 patients in August 2001, and 5 (29%) were subsequently hospitalized for infections at the site. S. aureus was isolated from 4 patients, and all 4 isolates were indistinguishable by pulsed-field gel electrophoresis. Of 10 patients injected with lidocaine and triamcinolone, 5 (50%) developed infections, compared with 0 of 7 patients injected with triamcinolone only (P=.04). A multiple-dose vial (MDV) of lidocaine was likely contaminated with S. aureus. A possible contributing factor was refrigeration after the use of MDVs of lidocaine; the manufacturer recommends storage at room temperature. An in vitro study of S. aureus in MDVs of lidocaine revealed prolonged survival at refrigerator temperatures. This outbreak highlights the importance of strict attention to aseptic procedures and carefully following manufacturers' instructions when using MDVs.

[1]  K. Ostrowska,et al.  An outbreak of Serratia marcescens associated with the anesthetic agent propofol. , 2001, American journal of infection control.

[2]  L. Grohskopf,et al.  Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. , 2001, The New England journal of medicine.

[3]  K. Kidd‐Ljunggren,et al.  Nosocomial transmission of hepatitis B virus infection through multiple-dose vials. , 1999, The Journal of hospital infection.

[4]  B. Pal,et al.  Perceived Risks of Joint Infection Following Intra-articular Corticosteroid Injections: A Survey of Rheumatologists , 1999, Clinical Rheumatology.

[5]  M. Pearson.  Guideline for Prevention of Intravascular-Device–Related Infections , 1996, Infection Control & Hospital Epidemiology.

[6]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[7]  C. Lehmann,et al.  Refrigeration of used multidose vials. , 1993, American journal of hospital pharmacy.

[8]  B. Schwartz,et al.  Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. , 1993, The Pediatric infectious disease journal.

[9]  J. Conly,et al.  Contamination Study of Multiple-Dose Vials , 1993, The Annals of pharmacotherapy.

[10]  J. Santell.  Expiration dating of multidose vials. , 1992, American journal of hospital pharmacy.

[11]  S. Solomon,et al.  Transmission of infectious diseases in outpatient health care settings. , 1991, JAMA.

[12]  W. Martone,et al.  Epidemic septic arthritis caused by Serratia marcescens and associated with a benzalkonium chloride antiseptic , 1987, Journal of clinical microbiology.

[13]  M. D. de Silva,et al.  Multidosage medication vials: a study of sterility, use patterns, and cost-effectiveness. , 1986, American journal of infection control.

[14]  K. Hyams,et al.  Sterility of anesthetic multiple-dose vials after opening. , 1985, Anesthesiology.

[15]  J. Coberly,et al.  Multiple-Dose Vials: Persistence of Bacterial Contaminants and Infection Control Implications , 1985, Infection Control.

[16]  R. Facklam,et al.  Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. , 1985, Pediatrics.

[17]  William N. Kelley,et al.  Textbook of rheumatology , 1985 .

[18]  J. Garner,et al.  CDC Recommendation Clarified , 1984, Infection Control.

[19]  K. Hyams,et al.  Multidose Medication Vial Sterility: An In-Use Study and a Review of the Literature , 1984, Infection Control.

[20]  K. Allman,et al.  Streptococcal abscesses following diphtheria‐tetanus toxoid‐pertussis vaccination , 1982, Pediatric infectious disease.

[21]  J. Burke,et al.  Sterility and use patterns of multiple-dose vials. , 1982, American journal of hospital pharmacy.

[22]  W. M. Heller.  Time limits on the use of opened multiple-dose vials. , 1980, American journal of hospital pharmacy.

[23]  C. Lehmann.  Effect of refrigeration on bactericidal activity of four preserved multiple-dose injectable drug products. , 1977, American journal of hospital pharmacy.

[24]  N. Brooks,et al.  Pseudomonas cepacia septic arthritis due to intra-articular injections of methylprednisolone. , 1977, Canadian Medical Association journal.

[25]  J. Bothe.  Study shows contamination in multiple-dose vials. , 1973, AORN journal.

[26]  J. Gaddum,et al.  United States Pharmacopeia , 1955, Nature.